Our AUD$200M investment in our North Ryde manufacturing facility in Sydney announced today will boost our capabilities to produce muchneeded medicines create many jobs and reinforce our commitment to Australia. httpsbit.ly2vgv8V7Â DominicRaabp

Our AUD$200M investment in our North Ryde manufacturing facility in Sydney, announced today, will boost our capabilities to produce much-needed medicines, create many jobs, and reinforce our commitment to Australia. https://bit.ly/2vgv8V7  @DominicRaabp

Our AUD$200M investment in our North Ryde manufacturing facility in Sydney, announced today, will boost our capabilities to produce much-needed medicines, create many jobs, and reinforce our commitment to Australia. https://bit.ly/2vgv8V7  @DominicRaab pic.twitter.com/jRcgBFZ4Wo

More From BioPortfolio on "Our AUD$200M investment in our North Ryde manufacturing facility in Sydney, announced today, will boost our capabilities to produce much-needed medicines, create many jobs, and reinforce our commitment to Australia. https://bit.ly/2vgv8V7  @DominicRaabp"